Function of Cystatin SN and its relationship with tumors

Abstract

Jiang Shanshan, Xin . Function of Cystatin SN and its relationship with tumors[J]. Journal of International Oncology, 2017, 44(3): 201-204.

［1］ Kim JT, Lee SJ, Kang MA, et al. Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity［J］. Cell Death Dis, 2013, 4: e974. DOI: 10.1038/cddis.2013.485. ［2］ Nandy SK, Bhuyan R, Seal A. Modelling family 2 cystatins and their interaction with papain［J］. J Biomol Struct Dyn, 2013, 31(6): 649-664. DOI: 10.1080/07391102.2012.706403. ［3］ Magister S, Kos J. Cystatins in immune system［J］. J Cancer, 2013, 4(1): 45-56. DOI: 10.7150/jca.5044. ［4］ SousaPereira SP, Abrantes J, Pinheiro A, et al. Evolution of C, D and Stype cystatins in mammals: an extensive gene duplication in primates ［J］. PLoS One, 2014, 9(10): e109050. DOI: 10.1371/journal.pone.0109050. ［5］ Morzel M, Chabanet C, Schwartz C, et al. Salivary protein profiles are linked to bitter taste acceptance in infants［J］. Eur J Pediatr, 2014, 173(5): 575-582. DOI: 10.1007/s004310132216z. ［6］ de SousaPereira SP, Amado F, Abrantes J, et al. An evolutionary perspective of mammal salivary peptide families: cystatins, histatins, statherin and PRPs［J］. Arch Oral Biol, 2013, 58(5): 451-458. DOI: 10.1016/j.archoralbio.2012.12.011. ［7］ Manconi B, Cabras T, Pisano E, et al. Modifications of the acidic soluble salivary proteome in human children from birth to the age of 48 months investigated by a topdown HPLCESIMS platform［J］. J Proteomics, 2013, 91(91): 536-543. DOI: 10.1016/j.jprot.2013.08.009. ［8］ Dsamou M, Morzel M, Le Corre L, et al. Caffeine increases the expression of cystatin SN in human submandibular acinarlike HSG cells［J ］. Arch Oral Biol, 2013, 58(10): 1511-1516. DOI: 10.1016/j.archoralbio.2013.06.005. ［9］ Sanna M, Firinu D, Manconi PE, et al. The salivary proteome profile in patients affected by SAPHO syndrome characterized by a topdown RPHPLCESIMS platform［J］. Mol Biosyst, 2015, 11(6): 1552-1562. DOI: 10.1039/c4mb00719k. ［10］ Dsamou M, Palicki O, Septier C, et al. Salivary protein profiles and sensitivity to the bitter taste of caffeine［J］. Chem Senses, 2012, 37(1): 87-95. DOI: 10.1093/chemse/bjr070. ［11］ Fornander L, Graff P, Whlén K, et al. Airway symptoms and biological markers in nasal lavage fluid in subjects exposed to metalworking fluids［J］. PLoS One, 2013, 8(12): e83089. DOI: 10.1371/journal.pone.0083089. ［12］ Imoto Y, Tokunaga T, Matsumoto Y, et al. Cystatin SN upregulation in patients with seasonal allergic rhinitis［J］. PLoS One, 2013, 8(8): e67057. DOI: 10.1371/journal.pone.0067057. ［13］ Yoneda K, Iida H, Endo H, et al. Identification of cystatin SN as a novel tumor marker for colorectal cancer［J］. Int J Oncol, 2009, 35(1): 33 -40. ［14］ Jiang J, Liu HL, Liu ZH, et al. Identification of cystatin SN as a novel biomarker for pancreatic cancer［J］. Tumour Biol, 2015, 36(5): 3903 -3910. DOI: 10.1007/s1327701430333. ［15］ Cao X, Li Y, Luo RZ, et al. Expression of cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected nonsmall cell lung cancer patients［J］. Sci Rep, 2015, 5: 8230. DOI: 10.1038/srep08230. ［16］ Blanco MA, Leroy G, Khan Z, et al. Global secretome analysis identifies novel mediators of bone metastasis［J］. Cell Res, 2012, 22(9): 1339-1355. DOI: 10.1038/cr.2012.89. ［17］ Liu XF, Xiang L, Zhang Y, et al. CAPC negatively regulates NFκB activation and suppresses tumor growth and metastasis［J］. Oncogene, 2012, 31(13): 1673-1682. DOI: 10.1038/onc.2011.355. ［18］ Keppler D, Zhang J, Bihani T, et al. Novel expression of CST1 as candidate senescence marker［J］. J Gerontol A Biol Sci Med Sci, 2011, 66 (7): 723-731. ［19］ Chen YF, Ma G, Cao X, et al. Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma［J］. BMC Surg, 2013, 13: 15. DOI: 10.1186/147124821315. ［20］ Choi EH, Kim JT, Kim JH, et al. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer［J］. Clin Chim Acta, 2009, 406 (12): 45-51. DOI: 10.1016/j.cca.2009.05.008. ［21］ Pramanik KC, Fofaria NM, Gupta P, et al. Inhibition of βcatenin signaling suppresses pancreatic tumor growth by disrupting nuclear βcatenin/TCF1 complex: critical role of STAT3［J］. Oncotarget, 2015, 6(13): 11561-11574. DOI: 10.18632/oncotarget.3427. ［22］ Mullapudi N, Ye B, Suzuki M, et al. Genome wide methylome alterations in lung cancer［J］. PLoS One, 2015, 10(12): e0143826. DOI: 10.1371/journal.pone.0143826. ［23］ Kim YI, Lee J, Choi YJ, et al. Proteogenomic study beyond chromosome 9: new insight into expressed variant proteome and transcriptome in human lung adenocarcinoma tissues［J］. J Proteome Res, 2015, 14(12): 5007-5016. DOI: 10.1021/acs.jproteome.5b00544

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Function of Cystatin SN and its relationship with tumors

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments